Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis

The aim of the study was to study the features of the clinical picture of the disease in patients with ACPA-negative and ACPA-positive variants of rheumatoid arthritis.Materials and methods. The study included patients with a reliable diagnosis of rheumatoid arthritis (RA) according to the criteria...

Full description

Saved in:
Bibliographic Details
Main Authors: D. A. Dibrov, A. S. Avdeeva, V. V. Rybakova, N. V. Demidova, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2023-04-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3323
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850043031832494080
author D. A. Dibrov
A. S. Avdeeva
V. V. Rybakova
N. V. Demidova
E. L. Nasonov
author_facet D. A. Dibrov
A. S. Avdeeva
V. V. Rybakova
N. V. Demidova
E. L. Nasonov
author_sort D. A. Dibrov
collection DOAJ
description The aim of the study was to study the features of the clinical picture of the disease in patients with ACPA-negative and ACPA-positive variants of rheumatoid arthritis.Materials and methods. The study included patients with a reliable diagnosis of rheumatoid arthritis (RA) according to the criteria of ACR/EULAR 2010. Depending on the values of the ACPA, two groups of patients were recruited: ACPA-positive and ACPA-negative, comparable in gender, age, duration of the disease and therapy. The nature of the onset and course of the disease, the activity of RA were evaluated (according to the DAS28, SDAI, CDAI indices).Results and discussion. The study included 79 patients with ACPA-negative variant of RA and 79 with ACPA-positive. Age of patients (Me [IR], in years) with the ACPA(–) variant was 52 [39; 62], with the ACPA(+) – 54 [42; 62], the duration of the disease (in months) is 59 [23; 122] and 48 [17; 84] respectively. In ACPA(+) patients, higher disease activity was determined by the indices DAS28-CRP, DAS28-ESR, SDAI, CDAI, values of C-reactive protein and erythrocyte sedimentation rate, a greater number of painful and swollen joints (p<0.05). According to the localization of the involved joints, arthritis of the proximal interphalangeal, metacarpal, wrist and shoulder joints was more often determined in ACPA(+) patients. Systemic manifestations of RA at the time of examination and in the anamnesis were statistically significantly more common in ACPA(+) (32.9%) than in ACPA(–) (17.7%). Of the systemic manifestations, rheumatoid nodules were more common in ACPA(+) patients, a tendency to a higher frequency of neuropathy, scleritis and episcleritis was revealed in ACPA(–) patients.Conclusion. In patients with ACPA(–) subtype, clinical signs of joint damage and the inflammatory component are less pronounced compared to ACPA(+). However, the mixed picture of manifestation, the less “bright” course of the disease, the absence of characteristic immunological biomarkers necessitate long-term and careful monitoring of this group of patients. At the same time, the subjective severity of the disease and dysfunction due to ankylosing joints do not differ from the ACPA(+) variant of RA.
format Article
id doaj-art-5ebc5e669ce746bda799f439bd7dd45a
institution DOAJ
issn 1995-4484
1995-4492
language Russian
publishDate 2023-04-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-5ebc5e669ce746bda799f439bd7dd45a2025-08-20T02:55:20ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922023-04-0161220721310.47360/1995-4484-2023-207-2132893Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritisD. A. Dibrov0A. S. Avdeeva1V. V. Rybakova2N. V. Demidova3E. L. Nasonov4V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University of the Ministry of Health Care of Russian Federation (Sechenov University)The aim of the study was to study the features of the clinical picture of the disease in patients with ACPA-negative and ACPA-positive variants of rheumatoid arthritis.Materials and methods. The study included patients with a reliable diagnosis of rheumatoid arthritis (RA) according to the criteria of ACR/EULAR 2010. Depending on the values of the ACPA, two groups of patients were recruited: ACPA-positive and ACPA-negative, comparable in gender, age, duration of the disease and therapy. The nature of the onset and course of the disease, the activity of RA were evaluated (according to the DAS28, SDAI, CDAI indices).Results and discussion. The study included 79 patients with ACPA-negative variant of RA and 79 with ACPA-positive. Age of patients (Me [IR], in years) with the ACPA(–) variant was 52 [39; 62], with the ACPA(+) – 54 [42; 62], the duration of the disease (in months) is 59 [23; 122] and 48 [17; 84] respectively. In ACPA(+) patients, higher disease activity was determined by the indices DAS28-CRP, DAS28-ESR, SDAI, CDAI, values of C-reactive protein and erythrocyte sedimentation rate, a greater number of painful and swollen joints (p<0.05). According to the localization of the involved joints, arthritis of the proximal interphalangeal, metacarpal, wrist and shoulder joints was more often determined in ACPA(+) patients. Systemic manifestations of RA at the time of examination and in the anamnesis were statistically significantly more common in ACPA(+) (32.9%) than in ACPA(–) (17.7%). Of the systemic manifestations, rheumatoid nodules were more common in ACPA(+) patients, a tendency to a higher frequency of neuropathy, scleritis and episcleritis was revealed in ACPA(–) patients.Conclusion. In patients with ACPA(–) subtype, clinical signs of joint damage and the inflammatory component are less pronounced compared to ACPA(+). However, the mixed picture of manifestation, the less “bright” course of the disease, the absence of characteristic immunological biomarkers necessitate long-term and careful monitoring of this group of patients. At the same time, the subjective severity of the disease and dysfunction due to ankylosing joints do not differ from the ACPA(+) variant of RA.https://rsp.mediar-press.net/rsp/article/view/3323anti-cyclic citrullinated peptide antibodiesrheumatoid arthritisacpa-negative rheumatoid arthritisseronegative rheumatoid arthritisclinical features
spellingShingle D. A. Dibrov
A. S. Avdeeva
V. V. Rybakova
N. V. Demidova
E. L. Nasonov
Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
Научно-практическая ревматология
anti-cyclic citrullinated peptide antibodies
rheumatoid arthritis
acpa-negative rheumatoid arthritis
seronegative rheumatoid arthritis
clinical features
title Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
title_full Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
title_fullStr Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
title_full_unstemmed Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
title_short Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
title_sort clinical features of acpa negative and acpa positive variants of rheumatoid arthritis
topic anti-cyclic citrullinated peptide antibodies
rheumatoid arthritis
acpa-negative rheumatoid arthritis
seronegative rheumatoid arthritis
clinical features
url https://rsp.mediar-press.net/rsp/article/view/3323
work_keys_str_mv AT dadibrov clinicalfeaturesofacpanegativeandacpapositivevariantsofrheumatoidarthritis
AT asavdeeva clinicalfeaturesofacpanegativeandacpapositivevariantsofrheumatoidarthritis
AT vvrybakova clinicalfeaturesofacpanegativeandacpapositivevariantsofrheumatoidarthritis
AT nvdemidova clinicalfeaturesofacpanegativeandacpapositivevariantsofrheumatoidarthritis
AT elnasonov clinicalfeaturesofacpanegativeandacpapositivevariantsofrheumatoidarthritis